NinePointTwo Capital’s AdaptHealth AHCO Stock Holding History

NinePointTwo Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-26,939	Closed	-$327K	–	250
2023 Q2	$327K	Buy	+26,939	New	+$300K	0.13%	46

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

NinePointTwo Capital's AHCO Position: Q3 2023 in Review

NinePointTwo Capital sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 26,939 shares — an estimated $327K sold.

NinePointTwo Capital first reported a position in AHCO in Q2 2023 and held it in 1 quarter. The position peaked at $327K in Q2 2023. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

NinePointTwo Capital reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
NinePointTwo Capital sold 26,939 AdaptHealth shares in Q3 2023, an estimated $327K.
NinePointTwo Capital first reported a position in AdaptHealth in Q2 2023 and held it in 1 quarter.
NinePointTwo Capital's AdaptHealth position peaked at $327K in Q2 2023.
191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.